Xtant Medical to Announce Q2 2025 Earnings on August 12, 2025.
PorAinvest
miércoles, 6 de agosto de 2025, 3:10 am ET1 min de lectura
XTNT--
Investors can access the call via phone or webcast, with a replay available on the company's website. The announcement provides insights into the company's performance and strategic direction. Details of the conference call include a domestic dial-in number (877-545-0523), an international dial-in number (973-528-0016), and a passcode (482755). The webcast link is available at [Xtant Medical Q2 2025 Financial Results](https://www.webcaster4.com/Webcast/Page/3039/52698).
Xtant Medical Holdings, Inc. is dedicated to honoring the gift of donation, allowing patients to live full and complete lives. The company focuses on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. The company operates with the highest integrity to serve its customers.
References
[1] https://www.nasdaq.com/press-release/xtant-medical-announce-second-quarter-2025-financial-results-august-12-2025-2025-08
[2] https://finance.yahoo.com/news/xtant-medical-announce-second-quarter-120000784.html
[3] https://www.stocktitan.net/news/XTNT/xtant-medical-to-announce-second-quarter-2025-financial-results-on-11qn3tksxap9.html
Xtant Medical Holdings will announce Q2 2025 financial results on August 12, 2025. CEO Sean Browne and CFO Scott Neils will host a conference call at 8:30 AM ET. Investors can access the call via phone or webcast, with a replay available on the company's website. The announcement provides insights into the company's performance and strategic direction.
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has scheduled the release of its second quarter 2025 financial results for August 12, 2025, before market open. The company will host a conference call at 8:30 AM ET on the same day, featuring President and CEO Sean Browne and CFO Scott Neils.Investors can access the call via phone or webcast, with a replay available on the company's website. The announcement provides insights into the company's performance and strategic direction. Details of the conference call include a domestic dial-in number (877-545-0523), an international dial-in number (973-528-0016), and a passcode (482755). The webcast link is available at [Xtant Medical Q2 2025 Financial Results](https://www.webcaster4.com/Webcast/Page/3039/52698).
Xtant Medical Holdings, Inc. is dedicated to honoring the gift of donation, allowing patients to live full and complete lives. The company focuses on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. The company operates with the highest integrity to serve its customers.
References
[1] https://www.nasdaq.com/press-release/xtant-medical-announce-second-quarter-2025-financial-results-august-12-2025-2025-08
[2] https://finance.yahoo.com/news/xtant-medical-announce-second-quarter-120000784.html
[3] https://www.stocktitan.net/news/XTNT/xtant-medical-to-announce-second-quarter-2025-financial-results-on-11qn3tksxap9.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios